Eradivir

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$30.1M

Investors

9 investors across all rounds

Biomedical Advanced Research and Development Authority

National Science Foundation Innovation Corps Program

Ollin Ventures

Park City Angels

Philip Low

+4 more investors

Explore More Data

Detailed analysis for Eradivir

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Eradivir Leadership & Investors

Eradivir is led by a team of experienced leaders. The company has attracted investment from 9 institutional and strategic investors.

Who Has Invested in Eradivir?

Eradivir has raised $30.1M from 9 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Eradivir shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.